ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

XRTX Xortx Therapeutics Inc

2,65
-0,15 (-5,36%)
Dernière mise à jour : 19:05:55
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Xortx Therapeutics Inc XRTX TSX Venture Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,15 -5,36% 2,65 19:05:55
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,65 2,65 2,65 2,80
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
04/6/202414:30GLOBEXORTX to Present at BIO International Convention 2024
17/5/202413:00GLOBEXORTX Reprices Balance of Warrants Issued in Connection with..
30/4/202419:54GLOBEXORTX Reprices Warrants Issued in Connection with Previous..
22/4/202413:00GLOBEXORTX Announces Publication of Key Research in ADPKD
08/4/202413:30GLOBEXORTX Welcomes New Member to the Board of Directors
08/4/202413:00GLOBEXORTX Announces Participation in Spring 2024 Investor..
27/3/202410:00GLOBEXORTX Announces New Clinical Advisory Board Member
19/3/202410:00GLOBEXORTX Highlights Achievements of 2023 and Preparation for..
11/3/202412:00GLOBEXORTX Reprices Warrants Issued in Connection with Previous..
04/3/202413:00GLOBEXORTX Finalizes $2.7 Million Prospectus Supplement and..
15/2/202413:00GLOBEXORTX Raises $2.5 Million Under Prospectus Supplement and..
02/2/202402:46GLOBEXORTX Files an Amended and Restated Prospectus Supplement..
15/1/202413:00GLOBEXORTX Announces $2 Million Public Offering
03/1/202413:00GLOBEXORTX Submits a New Patent for the Treatment of Chronic..
02/1/202413:00GLOBEXORTX Welcomes New Member to the Board of Directors
30/11/202313:30GLOBEXORTX Announces US ATM Offering
29/11/202313:00GLOBEXORTX Meets Nasdaq Continued Listing Requirements
10/11/202313:00GLOBEXORTX Clarifies Timing for Share Consolidation
08/11/202323:00GLOBEXORTX Announces Share Consolidation
02/11/202312:00GLOBEXORTX Sponsored Study Presented at the American Society of..
27/10/202323:30GLOBEXORTX Announces Results of Special Meeting of Shareholders
25/10/202323:00GLOBEXORTX Announces Date for Rescheduled Special Meeting of..
25/10/202313:00GLOBEXORTX Announces Rescheduling of Special Meeting of..
12/10/202313:00GLOBEXORTX Reports that Independent Proxy Firm, ISS, Recommends..
04/10/202313:00GLOBEXORTX Calls Special Meeting of Shareholders
28/9/202313:00GLOBEXORTX Sponsored Study Selected for Presentation at the..
11/9/202313:00GLOBEXORTX Announces Participation at Upcoming Investor..
07/9/202313:00GLOBEXORTX Joins the Kidney Foundation and Kidney March
29/8/202313:00GLOBEXORTX Submits Orphan Drug Designation Application to the..
04/8/202323:00GLOBEXORTX Appoints Chief Financial Officer
29/6/202314:00GLOBEXORTX Announces Results of Annual and Special Meeting of..